Patent · US Active

Use of glycan as biomarkers for autoimmune diseases

US10234454B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Macau University of Science and Technology · CN

Inventors

Liang Liu · Macau, CN
Jing Wang · Beijing, CN
Weina Gao · Macau, CN
Leefong Yau · Macau, CN
Hao Huang
Qiong Meng · Macau, CN
Tiantian Tong · Macau, CN
Zhi-Hong Jiang · Taipa, CN

Key dates

Filing date	Oct 15, 2015
Grant date	Mar 19, 2019
Priority date	—
Expiry date	Feb 16, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/2575
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention discloses a method of determining the presence of autoimmune disease with the use of glycan biomarkers. A method of improving the detection sensitivity of trace glycans from a mixture of glycans and a microfluidic chip therefor are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.